home > events calendar > more about event

4th Annual Formulation & Drug Delivery Congress

Oxford Global - 4th Annual Formulation & Drug Delivery Congress

8-9 May 2018
London, UK

Oxford Global are proud to present our hugely popular 4th Annual Formulation & Drug Delivery Congress, 8th – 9th May 2018, London, UK.Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.

Including 5 interactive streams:

  • Large Molecule Drug Formulation
  • Advances in Drug Delivery
  • Drug Delivery Devices
  • Small Molecule Drug Formulation
  • Bioanalysis and Stabilisation

Featuring exclusive presentations on regulatory updates and targeted therapies

Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery Congress covering the development and formulation of inhaled therapies and inhalation devices & analytics.

View the Agenda here:

Free Pre-Congress Webinar Recordings

Advances in Small Drugs Formulation Research
David Elder, Director, Product Development, GlaxoSmithKline & René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S

Download today for free:

API Physical Form Selection: Chances vs Challenges For Formulation Development

Axel Becker, Senior Scientist, Merck KGaA

Download today for free:

For further information, prices & discounts please contact

phone +44 (0)1865 248455
email Oxford Global Ltd, Part 1st Floor, Godstow Court, Minns Business Park, Botley, Oxford, OX2 0JB
Print this page
Send to a friend
Industry Events

Cell Line Development and Engineering

23-25 April 2018, RAI, Amsterdam

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe.
More info >>

Banner of ChinaBio_Events_102 on Samedan
White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research


Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

News and Press Releases

Pharma Regulation in a Post-Brexit Landscape

As European pharmaceutical companies invest in new areas of gene and cell therapy, the regulations surrounding these medicinal areas are becoming more and more complex and evolving at a rapid rate. These industry developments add to an ever-changing regulatory landscape, which has led to pharmaceutical regulatory consultancies being increasingly brought in to help these companies navigate the highly technical challenges.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement